Inclusion body myositis (IBM)

Inclusion body myositis combines inflammation with a slower, degenerative process inside muscle fibers, and research describes findings such as abnormal accumulations of amyloid-beta and phosphorylated tau protein within muscle cells, thought to contribute to cellular stress and progressive fiber damage alongside immune-cell involvement.

It is the most common inflammatory muscle disease diagnosed after age 50, and a large population-based study estimated its point prevalence at roughly 3.3 per 100,000 people, more common in men than women at about a 3-to-2 ratio, with an average age at diagnosis around 67. Diagnosis is often delayed by more than five years on average, and the condition tends to progress gradually and respond less consistently to the anti-inflammatory treatments that help other inflammatory myopathies.

Common signs

Slowly worsening weakness that characteristically affects the muscles that bend the fingers and grip, and the muscles at the front of the thighs (quadriceps), leading to falls, trouble with stairs, and difficulty with fine hand tasks. Swallowing difficulty can develop, and the weakness is often not symmetrical, affecting one side more than the other.

This is a plain-language summary for orientation, not a diagnosis. Mechanisms are described as current understanding, not settled fact. Work with your own clinician for your care.